Personalized therapy in oncology: melanoma as a paradigm for molecular-targeted treatment approaches
Clinical & Experimental Metastasis · 2024
DOI: 10.1007/s10585-024-10291-5 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical & Experimental Metastasis, 2024. Verfasst von Kevin B Kim. Beteiligte Einrichtung: California Pacific Medical Center Research Institute, 2333 Buchanan St, San Francisco, CA, 94115, USA. kimkb@sutterhealth.org. Hauptthemen laut MEDLINE: Melanoma, Precision Medicine, Molecular Targeted Therapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 60 Literaturangaben.
Abstract (Originalsprache)
In recent decades, the field of systemic cancer treatment has seen remarkable changes due to advancements in the understanding of cancer's biology, immunology, and genetic makeup. As a result, individuals with late-stage cancers are now achieving survival rates that were previously unattainable. The goal of personalized cancer therapy is to enhance clinical outcomes by customizing drug treatments to suit the unique genetic and/or epigenetic profiles of each patient's tumor. This approach aims to reduce the side effects commonly associated with ineffective treatments. Advances in genetic sequencing and molecular cytogenetics have been instrumental in identifying cancer-driving mutations and epigenetic irregularities, leading to the development of specific molecular therapies. This review article highlights the progress and success of targeted molecular therapies in treating malignant melanoma, illustrating the concept of personalized cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- California Pacific Medical Center Research Institute, 2333 Buchanan St, San Francisco, CA, 94115, USA. kimkb@sutterhealth.org.
ORCID-Profile: Kevin B Kim
Zitieren
APA
Kim, K. B. (2024). Personalized therapy in oncology: melanoma as a paradigm for molecular-targeted treatment approaches. Clinical & Experimental Metastasis. https://doi.org/10.1007/s10585-024-10291-5
Vancouver
Kim KB. Personalized therapy in oncology: melanoma as a paradigm for molecular-targeted treatment approaches. Clinical & Experimental Metastasis. 2024. doi:10.1007/s10585-024-10291-5
BibTeX
@article{Kim2024,
author = {Kim, Kevin B},
title = {Personalized therapy in oncology: melanoma as a paradigm for molecular-targeted treatment approaches},
journal = {Clinical & Experimental Metastasis},
year = {2024},
doi = {10.1007/s10585-024-10291-5}
}
EUVIMED